Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “IGF1R”

85 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 85 results

Large-scale testing (Phase 3)Study completedNCT06269393
What this trial is testing

IBI311 in Subjects With Steroid-resistant, Thyroid Associated Ophthalmopathy

Who this might be right for
Thyroid Associated Ophthalmopathy
Peking University People's Hospital 53
Early research (Phase 1)Study completedNCT01122199
What this trial is testing

Study of RAD001 + AMG479 for Patients With Advanced Solid Tumors

Who this might be right for
Neoplasm Metastases
Shadia Jalal 27
Testing effectiveness (Phase 2)Ended earlyNCT00774878
What this trial is testing

Study of AVE1642 (IGF-1R/CD221) in Combination With Fulvestrant (Faslodex®) in Postmenopausal Patients With Advanced Hormono-dependent Breast Cancer

Who this might be right for
Breast Neoplasms
Sanofi 18
Testing effectiveness (Phase 2)Study completedNCT00630552
What this trial is testing

QUILT-2.019: A Study of AMG 655 or AMG 479 in Combination With Gemcitabine for Treatment of Metastatic Pancreatic Cancer

Who this might be right for
Adenocarcinoma of the PancreasMetastatic Pancreatic CancerPancreatic Cancer
NantCell, Inc. 138
Early research (Phase 1)Study completedNCT01536145
What this trial is testing

CP-751,871 Treatment For Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma
Pfizer 47
Early research (Phase 1)Temporarily pausedNCT01779336
What this trial is testing

Clinical Study of Oral IGF-1R Inhibitor in Subjects With Advanced Refractory Solid Tumors

Who this might be right for
Advanced Refractory Solid Tumors
Piramal Enterprises Limited 70
Post-approval studies (Phase 4)Looking for participantsNCT07152340
What this trial is testing

The Safety and Efficacy of Sequential Hormone Therapy and IBI311 Therapy in Patients With Active Moderate to Severe TAO in the Initial Treatment.

Who this might be right for
Thyroid Associated Ophthalmopathies
Shanghai Changzheng Hospital 64
Testing effectiveness (Phase 2)Study completedNCT01561456
What this trial is testing

Study of AXL1717 Compared to Docetaxel to Treat Squamous Cell Carcinoma or Adenocarcinoma of the Lung

Who this might be right for
Non-small-cell Lung CancerSquamous Cell CarcinomaAdenocarcinoma of the Lung
Axelar AB 100
Early research (Phase 1)Study completedNCT00785941
What this trial is testing

IMC-A12 Every 2 Weeks in Patients With Tumors Who No Longer Respond to Treatment or No Treatment is Available

Who this might be right for
Advanced Solid Tumors
Eli Lilly and Company 16
Not applicableUnknownNCT02719041
What this trial is testing

Predictive Biomarkers for IGF1R Targeted Therapy in Ovarian Cancer: a Retrospective Study

Who this might be right for
Ovarian Cancer
Hillel Yaffe Medical Center 40
Testing effectiveness (Phase 2)Study completedNCT00563680
What this trial is testing

QUILT-3.025: A Phase 2 Study of AMG 479 in Relapsed or Refractory Ewing's Family Tumor and Desmoplastic Small Round Cell Tumors

Who this might be right for
Askin's TumorsDesmoplastic Small Round Cell TumorsEstraosseous Ewing's Tumor+4 more
NantCell, Inc. 38
Early research (Phase 1)Study completedNCT00609141
What this trial is testing

IMC-A12 in Treating Young Patients With Relapsed or Refractory Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor or Other Solid Tumor

Who this might be right for
Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal TumorUnspecified Childhood Solid Tumor, Protocol Specific
National Cancer Institute (NCI) 34
Large-scale testing (Phase 3)Looking for participantsNCT06112340
What this trial is testing

Extension Study of Two Doses of Linsitinib in Subjects With Active, Moderate to Severe Thyroid Eye Disease (TED)

Who this might be right for
Thyroid Eye DiseaseGraves OrbitopathyEndocrine System Diseases+9 more
Sling Therapeutics, Inc. 75
Early research (Phase 1)Study completedNCT00970580
What this trial is testing

BIIB022 in Combination With Paclitaxel and Carboplatin in Subjects With Non-Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
Biogen 18
Not applicableStudy completedNCT00898898
What this trial is testing

Studying Tissue Samples From Women With Breast Cancer Who Were Treated on Clinical Trial NCCTG-N9831

Who this might be right for
Breast Cancer
Alliance for Clinical Trials in Oncology 2,837
Testing effectiveness (Phase 2)Study completedNCT00887159
What this trial is testing

Phase II Study of Cisplatin and Etoposide in Combination With Either Hedgehog Inhibitor GDC-0449 or IGF-1R MOAB IMC-A12 for Patients With Extensive Stage

Who this might be right for
Extensive Stage Small Cell Lung CarcinomaRecurrent Small Cell Lung Carcinoma
National Cancer Institute (NCI) 168
Testing effectiveness (Phase 2)Study completedNCT00684983
What this trial is testing

Capecitabine and Lapatinib Ditosylate With or Without Cixutumumab in Treating Patients With Previously Treated HER2-Positive Stage IIIB-IV Breast Cancer

Who this might be right for
HER2 Positive Breast CarcinomaRecurrent Breast CarcinomaStage IIIB Breast Cancer AJCC v7+2 more
National Cancer Institute (NCI) 64
Not applicableStudy completedNCT04767750
What this trial is testing

Role of LncRNA H19 in The Regulation of IGF-1R Expression

Who this might be right for
Hepatocellular CarcinomaType 2 DiabetesCancer
Mansoura University 101
Testing effectiveness (Phase 2)Study completedNCT02546544
What this trial is testing

Eurosarc Trial of Linsitinib in Advanced Ewing Sarcoma

Who this might be right for
Relapsed Ewing SarcomaRefractory Ewing Sarcoma
University of Oxford 16
Testing effectiveness (Phase 2)Study completedNCT00719212
What this trial is testing

Study of AMG 479 as Second Line Therapy in Patients With Recurrent Platinum-sensitive Ovarian Cancer

Who this might be right for
Ovarian Neoplasms
Translational Research in Oncology 61
Load More Results